Data & Analysis
Data & Analysis · page 6
- UK & Europe
Legal Sources Now the First Choice for Cannabis Users in Germany
Since Germany’s Cannabis Act (CanG) came into force on 1 April 2024, much has changed regarding what was once the country’s most widely used illegal drug.
- Legal Analysis
How Has the UK Government’s Position on Cannabis Changed Under Labour?
The UK’s cannabis industry, one of the largest on the planet, sits at a crossroads.
- Legal Analysis
Switzerland Plans for a Single Online Cannabis Retailer: What Will This Mean for its Upcoming Adult-Use Market?
Switzerland’s draft cannabis plan proposes a single online retailer, raising opportunities and risks as it pursues Europe’s first adult-use market.
- Cultivation
Overwhelming Majority (80%) of Canadian Cannabis Now Sourced from Legal Distributors in Major Turnaround
Nearly 80% of Canadian’s now source their cannabis solely from the legal market, marking a stark shift away from the illicit market seven years after legalisation.
- Legal Analysis
Germany’s Medical Market Continues Record Growth in the Face of Clampdown
The blistering growth of Germany’s medical cannabis sector showed no signs of abating through the second quarter of 2025, with imports rising another 15% to hit new records.
- Legal Analysis
Seizures of Cannabis Smuggled Into Germany Have Risen 50% Despite Reforms
You can also read this story in German, here. When the Cannabis Act came into force in Germany, the aim was to improve the country’s drug policy by changing the way the popular recreational drug was handled.
- Medical Cannabis
Why France’s Strict Medical Cannabis Plans Could be its Secret Weapon
Augur Associates and Newsweed, two organisations at the forefront of the ongoing developments in the region, believe that the incoming system not only sidesteps many of the issues other countries have faced in the implementation phase, but that it could reestablish the country’s standing as a model of inspiration for neighbouring states and prospective forthcoming EU supra-regulation.
- Industry Trends
Why the UK’s Steady Medical Cannabis Market Growth Is Its Biggest Advantage
Though less explosive than markets like Germany or Australia, the UK has continued to evolve in a more controlled manner, enabling it to largely avoid the scrutiny and intervention that have accompanied rapid expansion elsewhere.
- Pharmaceutical
Standard Seed AI’s Platform Could Rewrite the Future of Cannabis Drug Discovery
At its core, Standard Seed AI’s technology has the power to scientifically validate the entourage effect, streamline drug discovery, and drastically reduce the time and cost of bringing cannabis-based medicines to market.
- Data & Analysis
What Comes Next for UK Medical Cannabis?
Though large-scale reform does not currently appear forthcoming, there are small-scale, more targeted measures that could feasibly be taken by UK authorities in the coming years which would be positive for the medical cannabis industry.
- Data & Analysis
Germany’s Green Rush: Medical Cannabis Imports Continue Record Growth, As Political Pushback Grows in Tandem
German medical cannabis imports have continued their meteoric rise in the wake of the passage of its Cannabis Act (CanG), rising a further 15% on Q4, 2024 in the first quarter of 2025, totalling 37,223 kg.
- Data & Analysis
The ‘Glaring Omission’ of the Endocannabinoid System From Mainstream Medical Knowledge, And its Real World Impact
Despite being one of the most important regulatory systems in human physiology, the endocannabinoid system (ECS) remains inexplicably absent from almost all mainstream medical education.
